Document Control Deficiencies – US
USFDA 483 to UCB Belgium cites fundamental gaps in document control – uncontrolled forms for
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
